Why did Ravens back out of Crosby trade?

Blockbuster deal collapses after medical red flag

A proposed trade that would have sent an elite pass rusher to Baltimore unraveled when the acquiring team declined to proceed after a post-agreement medical review. The Las Vegas franchise confirmed the Baltimore side “backed out,” and multiple outlets reported a failed physical was the proximate cause. The player — for now — returns to his original team and the previously discussed exchange of draft compensation is void.

The collapse has immediate and wide-ranging consequences. The acquiring club keeps its draft assets and cap flexibility; the original team retains its star defender and the questions surrounding his health; and the broader market is suddenly active again. The player’s representatives issued public updates indicating the player remains on track in his recovery timeline, attempting to tamp down uncertainty about long-term availability.

Key ramifications

• Roster and cap: The original team retains a top pass rusher it had been prepared to move and must reconcile offseason plans around him.
• Market ripple: Several clubs that showed interest earlier have been tipped back on to the radar, creating a new round of scouting and trade chatter.
• Medical focus: Teams will pay extra attention to the medical follow-ups; any lingering concerns could limit trade leverage or alter contract structure.

What happens next is straightforward but delicate: the player undergoes further evaluation, the original team decides whether to try trading him again or keep him on the roster, and potential suitors weigh medical reports against on-field value. The episode underscores how heavily modern transactions depend on pre-close medical clearance and how one medical finding can reshape an entire offseason.